Comparison of intranasal and nebulized dexmedetomidine for premedication in pediatric patients: A non-inferiority randomized controlled trial
Background and Aims: Dexmedetomidine is a highly selective α-2 adrenoreceptor agonist and has been found to be an effective premedication agent when administered via the intranasal route. We aimed to compare the efficacy of dexmedetomidine premedication administered via intranasal route and through...
Saved in:
Main Authors: | Shilpi Verma (Author), Pradeep Kumar Bhatia (Author), Vandana Sharma (Author), Sadik Mohammed (Author), Anita Saran (Author) |
---|---|
Format: | Book |
Published: |
Wolters Kluwer Medknow Publications,
2022-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Comparison between intranasal dexmedetomidine and intranasal midazolam as premedication for brain magnetic resonance imaging in pediatric patients: A prospective randomized double blind trial
by: Ayushi Gupta, et al.
Published: (2017) -
Effects of intranasal dexmedetomidine versus intranasal midazolam as premedication in children with tetralogy of Fallot undergoing corrective cardiac surgery: A randomized trial
by: Sarvesh Srivastava, et al.
Published: (2024) -
Intranasal dexmedetomidine vs. oral midazolam for premedication in children: a systematic review and meta-analysis
by: Guangxuan Zhang, et al.
Published: (2023) -
A randomized double blind comparative study of dexmedetomidine with midazolam for intranasal premedication in children undergoing ophtalmic surgery.
by: D. Singla, et al.
Published: (2018) -
The effect of dexmedetomidine nebulization as a premedication prior to peripheral intravenous access in pediatric patients and its effect on separation anxiety score and acceptance to intravenous cannulation score.
by: D. M. Bonagua, et al.
Published: (2020)